In recent years, Novogene Europe has systematically integrated state-of-the-art technologies across its service portfolio, ...

For this edition of the CIIE, Illumina has brought its new NovaSeq X Plus, which is making its global debut at the expo. As the company's highest-throughput, highest-capacity, and most sustainable ...

We validate these inversions using new genome assemblies created using PacBio Hifi reads. Finally, we use existing and newly generated short-read Illumina sequencing to genotype these inversions in ...

2024 – Illumina’s NovaSeq X transforms the market The new flagship platform boosts speed, reduces costs to ~$200 per genome, and brings clinical-grade sequencing closer to reality.

China imposed an import ban on Illumina’s gene sequencers in response to President Trump’s escalating tariffs and trade war.

China banned the import of Illumina Inc. gene-sequencing machines as part of a wave of retaliatory measures against fresh US tariffs on all Chinese goods, deepening the US company’s woes in one ...

We believe that Illumina would be able to grow its TAM by continuing to reduce the cost of sequencing as it has in the past (its recent Novaseq X) has reduced the cost from $600 to $200.

Illumina, Inc., a global leader in DNA sequencing and array-based technologies, announced a series of updates to its NovaSeq X Series, delivering the NovaSeq X single-flow-cell system alongside a ...

Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced a series of updates to its NovaSeq X Series, delivering the NovaSeq X single-flow ...

In the rapidly evolving field of genomics, sequencing technologies play a crucial role in advancing our understanding of genetic material. Among the most prominent methods are Illumina sequencing and ...

The final pooled libraries were sequenced (150 bp paired-end, 600 million clusters) on Illumina NovaSeq 6000 Sequencing System. 2.12 Sequencing data processing We processed the FASTQ files obtained ...

Business Strategy and Outlook Illumina continues to focus on transforming human health practices through its leadership of genomic sequencing and related applications.